11.89
price up icon9.48%   1.03
pre-market  Vorhandelsmarkt:  11.84   -0.05   -0.42%
loading

Finanzdaten der Passage Bio Inc-Aktie (PASG)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Research and Development
25.80%
5.418
4.307 5.814 7.737 -
Operating Income/Loss
60.00%
-13.85
-8.655 -10.33 -16.46 -14.27
Income/Loss From Continuing Operations Before Tax
67.54%
-12.98
-7.749 -9.385 -15.40 -12.72
Income/Loss From Continuing Operations After Tax
67.54%
-12.98
-7.749 -9.385 -15.40 -12.72
Net Income/Loss
67.54%
-12.98
-7.749 -9.385 -15.40 -12.72
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
99.93%
0.0023
3.1787 3.1689 62.11 0.4845
Diluted Average Shares
99.93%
0.0023
3.1787 3.1689 62.11 0.4845
Basic Earnings Per Share
67.62%
-4.09
-2.44 -2.96 -0.25 -0.20
Diluted Earnings Per Share
67.62%
-4.09
-2.44 -2.96 -0.25 -0.20
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$54.26
price up icon 2.69%
$48.70
price down icon 0.25%
$99.47
price up icon 1.08%
$152.54
price up icon 3.76%
$146.74
price down icon 4.34%
ONC ONC
$319.94
price up icon 3.21%
Kapitalisierung:     |  Volumen (24h):